<DOC>
	<DOCNO>NCT00114062</DOCNO>
	<brief_summary>The purpose study determine whether denufosol tetrasodium ( INS37217 ) Intravitreal Injection well tolerate potential treat uveitis associate macular edema .</brief_summary>
	<brief_title>Study Treat Uveitis Associated Macular Edema</brief_title>
	<detailed_description>Denufosol tetrasodium ( INS37217 ) Intravitreal Injection may provide clinical benefit treatment uveitis associate macular edema ( UME ) reduce retinal thickness measure OCT possibly enable recovery vision loss associate UME . Denufosol tetrasodium may also reverse fluid accumulation UME .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Uveitis</mesh_term>
	<criteria>Have anterior uveitis , intermediate uveitis , posterior uveitis panuveitis least one eye Have persistent macular edema uveitis whose condition stable Have change medication regimen least 3 month prior randomization currently take medication immunosuppressive antiinflammatory agent ; steroidal nonsteroidal agent ( drop , oral inject ) Have OCT scan qualify retinal thickness study eye Have evidence macular edema OCT scan Have lease one eligible eye treat study base visual acuity . Have proliferative vitreoretinopathy great grade B Have subretinal vitreous hemorrhage , corneal opacity , condition , limit view retina obscure FA Have uncontrollable elevate IOP , advance , previous filtration surgery , current evidence endophthalmitis study eye Have ocular disorder study eye may confound interpretation study result Have cataract surgery study eye within 3 month , YAG laser capsulotomy within past 1 month , intraocular surgery within past 90 day Have preoperative spherical equivalent refractive error 10 diopter myopia study eye Have intravitreal periocular injection corticosteroid study eye 3 month prior screen Have ocular implant device delivery therapeutic agent eye Be take excluded medication could obscure confound study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>uveitis</keyword>
	<keyword>macular edema</keyword>
	<keyword>uveitis associate macular edema</keyword>
</DOC>